Gabelli & Co Investment Advisers’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,013,150	Closed	-$2.38M	–	303
2024 Q3	$2.38M	Buy	+1,013,150	New	+$2.04M	0.41%	60

Gabelli & Co Investment Advisers's AUGX Position: Q4 2024 in Review

Gabelli & Co Investment Advisers sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 1,013,150 shares — an estimated $2.38M sold.

Gabelli & Co Investment Advisers first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $2.38M in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Gabelli & Co Investment Advisers reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 1,013,150 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $2.38M.
Gabelli & Co Investment Advisers first reported a position in Augmedix, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Augmedix, Inc. Common Stock position peaked at $2.38M in Q3 2024.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2024, filed 13 Feb 2025.